Login to Your Account



Financings NEWS

LONDON – Iterum Therapeutics Ltd. has raised $65 million in an oversubscribed series B round to fund phase III development of sulopenem, a treatment in-licensed from Pfizer Inc. for gram-negative multidrug-resistant infections.

DUBLIN – Vesalius Biocapital Partners Sàrl has responded to Boston's gravitational pull by putting in place a plan to establish a presence in the world's foremost biotech hub as it raises €150 million (US$166.7 million) for its third fund, Vesalius Biocapital III (VBC III).

TAIPEI, Taiwan – Aslan Pharmaceuticals Pte. Ltd., a Singapore-based company focused on the development of treatments for prevalent tumor types in Asia, is conducting a competitive auction and public offer of common shares for its initial listing on the TPEx.

More Financings Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: